(Q38300425)

1 September 2017

1 reference

title

Natural history of chronic hepatitis B virus infection (English)

1 reference

1 September 2017

1 reference

1 reference

1 reference

Katrin Busch

1

1 reference

1 September 2017

Robert Thimme

series ordinal

2

1 reference

1 September 2017

publication date

25 December 2014

1 reference

Medical Microbiology and Immunology

1 September 2017

published in

1 reference

1 September 2017

volume

204

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

5-10

1 reference

The genome of a Mesozoic paleovirus reveals the evolution of hepatitis B viruses

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Genomic fossils calibrate the long-term evolution of hepadnaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Possible origins and evolution of the hepatitis B virus (HBV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Dating the origin and dispersal of hepatitis B virus infection in humans and primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Tracing hepatitis B virus to the 16th century in a Korean mummy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Morphogenesis of hepatitis B virus and its subviral envelope particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

The replication cycle of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Hepatitis B virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

HBV core sequence: definition of genotype-specific variability and correlation with geographical origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Intracellular transport of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

HBV life cycle and novel drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

The size of the viral inoculum contributes to the outcome of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Dynamics of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Genomic analysis of the host response to hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Temporal analysis of early immune responses in patients with acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Pathogenesis of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Management of hepatitis B: summary of a clinical research workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Epidemiology and natural history of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Immunosuppression and HBV reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Statements from the Taormina expert meeting on occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Occult hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Occult hepatitis B virus infection: detection and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Clinical impact of occult hepatitis B virus infection in immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Hepatitis B virus. The major etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

IL-10, T cell exhaustion and viral persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Interleukin-10 determines viral clearance or persistence in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Resolution of a chronic viral infection after interleukin-10 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Immune effectors required for hepatitis B virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Regulation of NK cell repertoire and function in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

TLR-dependent cross talk between human Kupffer cells and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

NK cells: a double-edged sword in chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00430-014-0369-7

21 January 2018

12 December 2020

Expression of the precore region of an avian hepatitis B virus is not required for viral replication

1 reference

12 December 2020

Immunochemical structure of hepatitis B e antigen in the serum

1 reference

12 December 2020

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

1 reference

12 December 2020

Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C

1 reference

12 December 2020

Functional interactions between dendritic cells and NK cells during viral infection

1 reference

12 December 2020

The natural history of chronic hepatitis B virus infection

1 reference

12 December 2020

Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis

1 reference

12 December 2020

Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen

1 reference

12 December 2020

Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte

1 reference

12 December 2020

Woodchuck hepatitis virus X protein is required for viral infection in vivo

1 reference

12 December 2020

Natural killer cells act as rheostats modulating antiviral T cells

1 reference

12 December 2020

Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis.

1 reference

12 December 2020

Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.

1 reference

12 December 2020

Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase

1 reference

12 December 2020

Assembly of hepadnaviral virions and subviral particles

1 reference

12 December 2020

Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence

1 reference

12 December 2020

In situ localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liver

1 reference

12 December 2020

The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host

1 reference

12 December 2020

10.1007/S00430-014-0369-7

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1004946985

0 references

1 reference